Literature DB >> 14694040

Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2.

R A Maselli1, J Wan, V Dunne, M Graves, R W Baloh, R L Wollmann, J Jen.   

Abstract

OBJECTIVE: To further investigate the basis of abnormal neuromuscular transmission in two patients with congenital myasthenic syndrome associated with episodic ataxia type 2 (EA2) using stimulated single fiber EMG (SFEMG) and in vitro microelectrode studies.
METHODS: Two patients with genetically characterized EA2 previously shown to have abnormal neuromuscular transmission by voluntary SFEMG were studied with stimulated SFEMG and anconeus muscle biopsy with microelectrode studies and electron microscopy of the neuromuscular junction.
RESULTS: In vivo stimulated SFEMG showed signs of presynaptic failure, with jitter and blocking that improved with increased stimulation frequency. Additional evidence of presynaptic failure was provided by the in vitro microelectrode studies, which showed marked reduction of the end plate potential quantal content in both patients. Of note, the end plate potentials showed high sensitivity to N-type blockade with omega-conotoxin not seen in controls. The ultrastructural studies revealed some evidence of small nerve terminals apposed to normal or mildly overdeveloped postsynaptic membranes, suggesting an ongoing degenerative process.
CONCLUSIONS: The authors demonstrated presynaptic failure of neurotransmission in patients with heterozygous nonsense mutations in CACNA1A. The contribution of non-P-type calcium channels to the process of neurotransmitter release in these patients likely represents a compensatory mechanism, which is insufficient to restore normal neuromuscular transmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694040     DOI: 10.1212/01.wnl.0000099748.41130.9a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

Review 2.  Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.

Authors:  Sanjeev Rajakulendran; Diego Kaski; Michael G Hanna
Journal:  Nat Rev Neurol       Date:  2012-01-17       Impact factor: 42.937

Review 3.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

4.  The first knockin mouse model of episodic ataxia type 2.

Authors:  Samuel J Rose; Lisa H Kriener; Ann K Heinzer; Xueliang Fan; Robert S Raike; Arn M J M van den Maagdenberg; Ellen J Hess
Journal:  Exp Neurol       Date:  2014-08-08       Impact factor: 5.330

Review 5.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

6.  In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.

Authors:  Susan E Tomlinson; S Veronica Tan; David Burke; Robyn W Labrum; Andrea Haworth; Vaneesha S Gibbons; Mary G Sweeney; Robert C Griggs; Dimitri M Kullmann; Hugh Bostock; Michael G Hanna
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

7.  A Novel Striated Muscle-Specific Myosin-Blocking Drug for the Study of Neuromuscular Physiology.

Authors:  Dante J Heredia; Douglas Schubert; Siddhardha Maligireddy; Grant W Hennig; Thomas W Gould
Journal:  Front Cell Neurosci       Date:  2016-12-01       Impact factor: 5.505

8.  A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating.

Authors:  Sidharth Tyagi; Tyler R Bendrick; Dilyana Filipova; Symeon Papadopoulos; Roger A Bannister
Journal:  J Gen Physiol       Date:  2019-04-23       Impact factor: 4.086

9.  Poor mother-offspring relationships in rats with Cacna1a mutation.

Authors:  Nozomi Kawakami; Kiyoka Kobayashi; Ayumu Nishimura; Iori Ohmori
Journal:  Exp Anim       Date:  2019-11-13

Review 10.  The ataxic Cacna1a-mutant mouse rolling nagoya: an overview of neuromorphological and electrophysiological findings.

Authors:  Jaap J Plomp; Arn M J M van den Maagdenberg; Simon Kaja
Journal:  Cerebellum       Date:  2009-05-30       Impact factor: 3.847

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.